Science • Medicine

Pfizer and US reach $1.95 billion deal for Covid-19 vaccine

The US government has agreed to pay $1.95 billion for 100 million Covid-19 vaccine doses to American pharmaceutical company Pfizer and German biotechnology company. The vaccine called BNT162 is currently still in development and early clinical trials. The agreement further states that the US could buy another 500 million doses, provided that the vaccine is both safe and effective as well as approved b the US Food and Drug Administration.

Highly edible human, designer of all things digital, co-founder of Pendect, creative native, constant wa/onderer, morse code lady, full-time dog pillow.
Card reviewed by: @ericof